rs3779134

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.90-19446G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0783 in 152,076 control chromosomes in the GnomAD database, including 612 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.078 ( 612 hom., cov: 32)

Consequence

TBXAS1
NM_001061.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0930

Publications

4 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001061.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
NM_001061.7
MANE Select
c.90-19446G>C
intron
N/ANP_001052.3P24557-1
TBXAS1
NM_001166253.4
c.90-19446G>C
intron
N/ANP_001159725.2P24557-3
TBXAS1
NM_001130966.5
c.90-19446G>C
intron
N/ANP_001124438.2P24557-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
ENST00000448866.7
TSL:1 MANE Select
c.90-19446G>C
intron
N/AENSP00000402536.3P24557-1
TBXAS1
ENST00000336425.10
TSL:1
c.90-19446G>C
intron
N/AENSP00000338087.7P24557-1
TBXAS1
ENST00000425687.5
TSL:1
c.-112-19446G>C
intron
N/AENSP00000388736.1P24557-2

Frequencies

GnomAD3 genomes
AF:
0.0783
AC:
11902
AN:
151958
Hom.:
610
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0196
Gnomad AMI
AF:
0.0396
Gnomad AMR
AF:
0.0599
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.0562
Gnomad SAS
AF:
0.106
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.0732
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0783
AC:
11905
AN:
152076
Hom.:
612
Cov.:
32
AF XY:
0.0768
AC XY:
5708
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.0196
AC:
812
AN:
41498
American (AMR)
AF:
0.0598
AC:
914
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0274
AC:
95
AN:
3468
East Asian (EAS)
AF:
0.0562
AC:
291
AN:
5182
South Asian (SAS)
AF:
0.105
AC:
508
AN:
4820
European-Finnish (FIN)
AF:
0.101
AC:
1067
AN:
10538
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.118
AC:
8013
AN:
67966
Other (OTH)
AF:
0.0748
AC:
158
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
557
1115
1672
2230
2787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
141
Bravo
AF:
0.0712
Asia WGS
AF:
0.101
AC:
352
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
12
DANN
Benign
0.76
PhyloP100
0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3779134; hg19: chr7-139552588; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.